Skip to main content

Animations

The Parkinson's Precision Medicine Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.


  • Northwestern University PPMI Site Featured in the Chicago Tribune

    Northwestern University PPMI Site Featured in the Chicago Tribune

    Yesterday the Chicago Tribune profiled Delores Slezak, a nurse in Illinois, and her decision to participate in the Parkinson's Progression Marker's Initiative (PPMI).
    Learn more Save for later

  • Default content image

    MJFF Research Staff Reflects on Some of 2011's Big Impact Projects

    This week, the MJFF research staff reflected on some of the projects they worked on in 2011 that they believe could have the greatest impact on the Parkinson’s disease (PD) patient community. 
    Learn more Save for later

  • PPMI Still Enrolling; First Results Coming In

    PPMI Still Enrolling; First Results Coming In

    The Parkinson’s Progression Markers Initiative (PPMI), the Foundation’s landmark clinical study to find biomarkers of Parkinson’s disease (PD), is now reporting its first results.
    Learn more Save for later

  • Default content image

    Clinical Trial Site in Boca Raton About to Join PPMI

    A clinical trial site in Boca Raton is about to join the Foundation’s PPMI study, and already, the site is getting media coverage.
    Learn more Save for later

  • Default content image

    New Study Protocol incorporating following subjects with SWEDD now posted

    An updated protocol has been posted to the PPMI site. This is the 3rd amendment to the protocol and incorporates a third cohort into the PPMI study.
    Learn more Save for later

  • Default content image

    Clinical Data and Biospecimens available for over 200 subjects

    We are pleased to announce that PPMI has now enrolled over 200 subjects.
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.